Cutting edge: Molecular analysis of the negative regulatory function of lymphocyte activation gene-3

Journal of Immunology

Volumn 169, Issue 10, 2002, Pages 5392-5395

  Workman, Creg J ^a   Dugger, Kari J ^a   Vignali, Dario A A ^a  

^a ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; LYSINE; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; CYTOPLASM; GENE; LIGAND BINDING; MOUSE; NONHUMAN; POINT MUTATION; PRIORITY JOURNAL; REGULATORY MECHANISM; T LYMPHOCYTE;

EID: 0037111520     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.169.10.5392     Document Type: Article

References (25)

1. Lenschow, D. J., T. L. Walunas, and J. A. Bluestone. 1996. CD28/B7 system of T cell costimulation. Annu. Rev. Immunol 14:233.
2. + T cell clone responses following LAG-3 binding. Eur. J. Immunol. 26:1180.
3. Baixeras, E., B. Huard, C. Miossec, S. Jitsukawa, M. Martin, T. Hercend, C. Auffray, F. Triebel, and D. Piatier-Tonneau. 1992. Characterization of the lymphocyte activation gene 3-encoded protein: A new ligand for human leukocyte antigen class II antigens. J. Exp. Med. 176:327.
4. Hannier, S., M. Tournier, G. Bismuth, and F. Triebel. 1998. CD3/TCR complex-associated lymphocyte activation gene-3 molecules inhibit CD3/TCR signaling. J. Immunol. 161:4058.
5. Triebel, F., S. Jitsukawa, E. Baixeras, S. Roman-Roman, C. Genevee, E. Viegas-Pequignot, and T. Hercend. 1990. LAG-3, a novel lymphocyte activation gene closely related to CD4. J. Exp. Med. 171:1393.
6. Bruniquel, D., N. Borie, and F. Triebel. 1997. Genomic organization of the human LAG-3/CD4 locus. Immunogenetics 47:96.
7. Huard, B., R. Mastrangeli, P. Prigent, D. Bruniquel, S. Donini, N. El-Tayar, B. Maigret, M. Dreano, and F. Triebel. 1997. Characterization of the major histocompatibility complex class II binding site on LAG-3 protein. Proc. Natl. Acad. Sci. USA 94:5744.
8. Huard, B., P. Gaulard, F. Faure, T. Hercend, and F. Triebel. 1994. Cellular expression and tissue distribution of the human LAG-3-encoded protein, an MHC class II ligand. Immunogenetics 39:213.
9. Workman. C. J., D. S. Rice, K. J. Dugger, C. Kurschner, and D. A. A. Vignali. 2002. Phenotypic analysis of the murine CD4-related glycoprotein, CD223 (LAG-3). Eur. J. Immunol. 32:2255.
10. Huard, B., P. Prigent, M. Tournier, D. Bruniquel, and F. Triebel. 1995. CD4/major histocompatibility complex class II interaction analyzed with CD4- and lymphocyte activation gene-3 (LAG-3)-Ig fusion proteins. Eur. J. Immunol. 25: 2718.
11. Miyazaki, T., A. Dierich, C. Benoist, and D. Mathis. 1996. Independent modes of natural killing distinguished in mice lacking Lag3. Science 272:405.
12. Mastrangeli, R., E. Micangeli, and S. Donini. 1996. Cloning of murine LAG-3 by magnetic bead bound homologous probes and PCR (gene-capture PCR). Anal. Biochem. 241:93.
13. Takemoto, Y., M. Furuta, X. K. Li, W. J. Strong-Sparks, and Y. Hashimoto. 1995. LckBPI, a proline-rich protein expressed in haematopoietic lineage cells, directly associates with the SH3 domain of protein tyrosine kinase p561ck. EMBO J. 14:3403.
14. Fukamachi, H., N. Yamada, T. Miura, T. Kato, M. Ishikawa, E. Gulbins, A. Altman, Y. Kawakami. and T. Kawakami. 1994. Identification of a protein. SPY75, with repetitive helix-turn-helix motifs and an SH3 domain as a major substrate for protein tyrosine kinase(s) activated by FcεRI cross-linking. J. Immunol. 152:642.
15. Gronwald, R. G., F. J. Grant, B. A. Haldeman, C. E. Hart, P. J. O'Hara, F. S. Hagen, R. Ross, D. F. Bowen-Pope. and M. J. Murray. 1988. Cloning and expression of a cDNA coding for the human platelet-derived growth factor receptor: Evidence for more than one receptor class. Proc. Natl. Acad. Sci. USA 85:3435.
16. Vignali, D. A. A., and K. M. Vignali. 1999. Profound enhancement of T cell activation mediated by the interaction between the T cell receptor and the D3 domain of CD4. J. Immunol. 162:1431.
17. Persons, D. A., J. A. Allay, E. R. Allay, R. J. Smeyne, R. A. Ashmun, B. P. Sorrentino, and A. W. Nienhuis. 1997. Retroviral-mediated transfer of the green fluorescent protein gene into murine hematopoietic cells facilitates scoring and selection of transduced progenitors in vitro and identification of genetically modified cells in vivo. Blood 90:1777.
18. Persons, D. A., M. G. Mehaffey, M. Kaleko, A. W. Nienhuis, and E. F. Vanin. 1998. An improved method for generating retroviral producer clones for vectors lacking a selectable marker gene. Blood Cells Mol. Dis. 24:167.
19. Allen, P. M., D. J. McKean, B. N. Beck, J. Sheffield, and L. H. Glimcher. 1985. Direct evidence that a class II molecule and a simple globular protein generate multiple determinants. J. Exp. Med. 162:1264.
20. Vignali, D. A. A., and J. L. Strominger. 1994. Amino acid residues that flank core peptide epitopes and the extracellular domains of CD4 modulate differential signaling through the T cell receptor. J. Exp. Med. 179:1945.
21. Arnold, P. Y., K. M. Vignali, T. B. Miller, P. S. Adams, N. L. La Gruta, L. Cauley, L. Haynes, S. L. Swain, D. L. Woodland, and D. A. A. Vignali. Reliable generation and use of MHC class II:1g fusion proteins for the identification of antigen-specific T cells. J. Immunol. 169:739.
22. Carson, R. T., K. M. Vignali, D. L. Woodland, and D. A. A. Vignali. 1997. T cell receptor recognition of MHC class II-bound peptide flanking residues enhances immunogenicity and results in altered TCR V region usage. Immunity 7:387.
23. Weber, S., and K. Karjalainen. 1993. Mouse CD4 binds MHC class 11 with extremely low affinity. Int. Immunol. 5:695.
24. Iouzalen, N., S. Andreae, S. Hannier, and F. Triebel. 2001. LAP, a lymphocyte activation gene-3 (LAG-3)-associated protein that binds to a repeated EP motif in the intracellular region of LAG-3, may participate in the down-regulation of the CD3/TCR activation pathway. Eur. J. Immunol. 31:2885.
25. Hannier, S., and F. Triebel. 1999. The MHC class II ligand lymphocyte activation r gene-3 is co-distributed with CD8 and CD3-TCR molecules after their engagement by mAb or peptide-MHC class I complexes. Int. Immunol. 11:1745.